Market Insight

Stay Up-To-Date With the Latest News in the DDR Inhibitors Space! 

In Collaboration with DDR Beacon Target Therapies


Download our exclusive DDRi insights data infographic to discover:

  • The link between ATR inhibitors (ATRi) and lung cancer
  • Combination trials with PARP inhibitors (PARPi)
  • The move towards targeting effector proteins by drug developer

And much more!


"Excellent overview of the current DDR, ATR and PARP field that also included forward-looking perspectives"

Executive Vice President & Chief Technology Officer - Arum Therapeutics